Schedule 13D ownership disclosure
Tobira Therapeutics Inc
Security class unavailable · CUSIP: 88883P101
Event date: 2015-05-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 285,679
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-15-000329
- Form type
- SC 13D
- Filer
- Domain Partners VI, L.P.
- CIK
- CIK 1298033
- Filed
- May 20, 2015
- Reporting period
- May 04, 2015
- Description
- Schedule 13D beneficial ownership